CH645631A5 - Process for the preparation of hydantoin derivatives - Google Patents
Process for the preparation of hydantoin derivatives Download PDFInfo
- Publication number
- CH645631A5 CH645631A5 CH679677A CH679677A CH645631A5 CH 645631 A5 CH645631 A5 CH 645631A5 CH 679677 A CH679677 A CH 679677A CH 679677 A CH679677 A CH 679677A CH 645631 A5 CH645631 A5 CH 645631A5
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- hydantoin
- hydroxy
- formula
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2287776 | 1976-06-03 | ||
| GB5034076 | 1976-12-02 | ||
| GB1214577 | 1977-03-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH645631A5 true CH645631A5 (en) | 1984-10-15 |
Family
ID=27256793
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH679677A CH645631A5 (en) | 1976-06-03 | 1977-06-02 | Process for the preparation of hydantoin derivatives |
| CH576/84A CH647511A5 (en) | 1976-06-03 | 1984-02-07 | Process for the preparation of hydantoin derivatives |
| CH57784A CH646426A5 (en) | 1976-06-03 | 1984-02-07 | Process for the preparation of hydantoin derivatives |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH576/84A CH647511A5 (en) | 1976-06-03 | 1984-02-07 | Process for the preparation of hydantoin derivatives |
| CH57784A CH646426A5 (en) | 1976-06-03 | 1984-02-07 | Process for the preparation of hydantoin derivatives |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS52151168A (fi) |
| CA (1) | CA1176261A (fi) |
| CH (3) | CH645631A5 (fi) |
| DE (1) | DE2724948A1 (fi) |
| DK (1) | DK244577A (fi) |
| ES (5) | ES459412A1 (fi) |
| FI (1) | FI71930C (fi) |
| FR (1) | FR2362839A1 (fi) |
| HU (1) | HU183046B (fi) |
| NL (1) | NL7706064A (fi) |
| NZ (1) | NZ184281A (fi) |
| SE (2) | SE446336B (fi) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1602188A (en) * | 1977-12-01 | 1981-11-11 | Wellcome Found | Hydantoin derivatives |
| DK391678A (da) * | 1977-09-05 | 1979-03-06 | Wellcome Found | Nitrogen-heterocycliske forbindelser fremgangsmaade til deres fremstilling samt deres anvendelse |
| DK543178A (da) * | 1977-12-01 | 1979-06-02 | Wellcome Found | Thiodydantoinderivater |
| DE2963795D1 (en) * | 1978-01-23 | 1982-11-11 | Beecham Group Plc | Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them |
| EP0004723A1 (en) * | 1978-03-30 | 1979-10-17 | Beecham Group Plc | Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them |
| GB1599740A (en) * | 1978-05-31 | 1981-10-07 | Wellcome Found | Hydantoin derivatives |
| EP0006352A1 (en) * | 1978-06-15 | 1980-01-09 | Beecham Group Plc | Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them |
| EP0007180B1 (en) * | 1978-06-15 | 1983-03-30 | Beecham Group Plc | Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them |
| AU4778279A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | Prostaglandin analogues |
| IL57504A0 (en) * | 1978-06-15 | 1979-10-31 | Beecham Group Ltd | Prostagandin analogues,their preparation and pharmaceutical compositions containing |
| IL59065A0 (en) * | 1979-01-18 | 1980-05-30 | Beecham Group Ltd | Hydantoin derivatives,their preparation pharmaceutical compositons containing them |
| JPS55151569A (en) * | 1979-05-09 | 1980-11-26 | Wellcome Found | Optically active heterocyclic compounds* their synthesis and medical blend containing them |
| US4684735A (en) * | 1985-07-01 | 1987-08-04 | Stauffer Chemical Company | Promotion of raney nickel hydrogenation catalyst |
| JP3022878U (ja) * | 1995-08-18 | 1996-04-02 | 有限会社春江加工 | ミニディスク用ケース |
| NZ532909A (en) | 2001-11-30 | 2006-08-31 | Lilly Co Eli | Peroxisome proliferator activated receptor agonists |
| US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
| EP1631355B1 (en) * | 2003-06-06 | 2014-08-13 | Allergan, Inc. | Piperidinyl prostaglandin e analogs |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1524818A (en) * | 1974-11-29 | 1978-09-13 | Beecham Group Ltd | 12-azaprostaglandins |
-
1977
- 1977-06-02 CA CA000280455A patent/CA1176261A/en not_active Expired
- 1977-06-02 DE DE19772724948 patent/DE2724948A1/de not_active Ceased
- 1977-06-02 JP JP6525277A patent/JPS52151168A/ja active Granted
- 1977-06-02 SE SE7706428A patent/SE446336B/xx unknown
- 1977-06-02 FR FR7716849A patent/FR2362839A1/fr active Granted
- 1977-06-02 NZ NZ184281A patent/NZ184281A/xx unknown
- 1977-06-02 CH CH679677A patent/CH645631A5/de not_active IP Right Cessation
- 1977-06-02 ES ES459412A patent/ES459412A1/es not_active Expired
- 1977-06-02 NL NL7706064A patent/NL7706064A/xx not_active Application Discontinuation
- 1977-06-02 HU HU77WE560A patent/HU183046B/hu unknown
- 1977-06-02 FI FI771763A patent/FI71930C/fi not_active IP Right Cessation
- 1977-06-02 DK DK244577A patent/DK244577A/da not_active Application Discontinuation
-
1978
- 1978-06-01 ES ES470428A patent/ES470428A1/es not_active Expired
-
1979
- 1979-02-28 ES ES478156A patent/ES478156A1/es not_active Expired
- 1979-06-28 ES ES482010A patent/ES482010A1/es not_active Expired
-
1980
- 1980-03-25 ES ES489883A patent/ES489883A0/es active Granted
-
1982
- 1982-05-19 SE SE8203161A patent/SE8203161L/sv not_active Application Discontinuation
-
1984
- 1984-02-07 CH CH576/84A patent/CH647511A5/de not_active IP Right Cessation
- 1984-02-07 CH CH57784A patent/CH646426A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES8103057A1 (es) | 1981-02-16 |
| ES470428A1 (es) | 1979-09-01 |
| SE7706428L (sv) | 1977-12-04 |
| ES459412A1 (es) | 1978-11-01 |
| JPS52151168A (en) | 1977-12-15 |
| ES489883A0 (es) | 1981-02-16 |
| SE446336B (sv) | 1986-09-01 |
| CA1176261A (en) | 1984-10-16 |
| JPS6222986B2 (fi) | 1987-05-20 |
| NL7706064A (nl) | 1977-12-06 |
| FR2362839B1 (fi) | 1980-02-01 |
| CH646426A5 (en) | 1984-11-30 |
| NZ184281A (en) | 1980-04-28 |
| ES482010A1 (es) | 1980-08-16 |
| DK244577A (da) | 1977-12-04 |
| FI71930C (fi) | 1987-03-09 |
| FR2362839A1 (fr) | 1978-03-24 |
| ES478156A1 (es) | 1979-11-01 |
| FI71930B (fi) | 1986-11-28 |
| CH647511A5 (en) | 1985-01-31 |
| FI771763A (fi) | 1977-12-04 |
| DE2724948A1 (de) | 1977-12-15 |
| SE8203161L (sv) | 1982-05-19 |
| HU183046B (en) | 1984-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2923815C2 (fi) | ||
| CH645631A5 (en) | Process for the preparation of hydantoin derivatives | |
| DE2914059A1 (de) | 4-thiazolidincarbonsaeuren, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
| DD251973A5 (de) | Verfahren zur herstellung von 3(2h)-pyridazinon-derivaten | |
| AT376977B (de) | Verfahren zur herstellung von neuen 5-substituierten oxazolidin-2,4-dionen und ihren salzen | |
| DE2229035A1 (de) | Cyclopentanderivate | |
| EP0041215A2 (de) | Imidazoazolalkensäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln | |
| CH623809A5 (en) | Process for the preparation of pyrrolidones | |
| US4486443A (en) | Hydantoin derivatives and pharmaceutical use | |
| DE60005818T2 (de) | 3-(arylsulfonylamino)-tetrahydrofuran-3-carbonsäure-hydroxamide | |
| EP0001238B1 (en) | Hydantoin derivatives, their synthesis, pharmaceutical formulations and intermediates in their preparation | |
| EP0025501B1 (de) | Neue N-Aminoalkylindol-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| EP0088323B1 (de) | Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln | |
| DE2917456C2 (fi) | ||
| DE2914793A1 (de) | Pyrrolidincarboxaldehyd- und piperidincarboxaldehyd-derivate, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende wirkstoffe | |
| DE2922070A1 (de) | Hydantoine und ihre verwendung in pharmazeutischen zubereitungen | |
| EP0012801A1 (de) | 2-(1-Phenyl-2,5-cyclohexadienyl)-äthylaminderivate, Verfahren zu deren Herstellung, deren Verwendung als pharmazeutische Wirkstoffe sowie diese enthaltende Arzneimittel | |
| EP0158312B1 (de) | 1-[Cyclohexyl]-3,4-di-[hydro]-isochinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| EP0065200B1 (de) | Delta-1-Pyrrolin-thiolactimäther und Verfahren zu ihrer Herstellung | |
| CH617920A5 (fi) | ||
| DE69911455T2 (de) | Hydrazin-derivate | |
| DE3141819C2 (fi) | ||
| AT374460B (de) | Verfahren zur herstellung von neuen substituierten hydantoinen und von deren salzen | |
| US4262128A (en) | Nitrogen heterocycles | |
| DE2825855A1 (de) | 15-substituierte- omega -pentanorprostaglandin-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |